CRISILNSECrisil Limited· FinanceMediumNeutral
Announced Fri, 17 Apr · 20:36 IST

CRISIL Limited has informed the Exchange about Investor Presentation

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

CRISIL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹4335.00
prior close
₹4360.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.5-0.7-1.6+0.4+0.2+0.6-1.6-1.0-0.4-6.7-3.3-2.8-2.3
Up moveDown movePending
AI summary

Crisil reported strong Q1 FY2026 results with income from operations up 30.1% year-on-year to Rs 813 crore, and profit after tax rising 45.9% to Rs 233 crore. The Ratings Services segment grew revenue 20.2% and expanded margin to 50.5%, while the Research, Analytics & Solutions segment posted 34.9% revenue growth with margin improving to 22.7%. The company declared an interim dividend of Rs 9 per share, up from Rs 8 in the same quarter last year. The rupee depreciation provided a near-term tailwind, with a foreign exchange gain of Rs 14.4 crore in the quarter versus a loss of Rs 5.2 crore in Q1 FY25. Management noted that accelerated renewals in Coalition Greenwich added approximately US$ 4.5 million of revenue in the quarter, expected to normalize over the year. Crisil is deploying domain-led GenAI products like GenEye Credit and DeepMine to boost competitiveness.

Likely market impact

The strong margin expansion across both segments signals operational leverage is kicking in. However, the one-time revenue boost from accelerated renewals means investors should watch for normalization in subsequent quarters.